HMS-5678

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHMS-5678
Drug Alias NameDorzagliatin+GLP-1Dorzagliatin add on to GLP1RAHMS-5678HMS5678
ClassificationSmall molecules
Mechanisms of ActionGlucokinase activatorsGlucagon-like peptide 1 receptor agonists
TargetsGlucokinaseGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes MellitusAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A